Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation

October 30, 2019 updated by: Lisa Alderson MD, F.A.C.C., St. Louis University
This study evaluates the compliance of patients in a Phase 2 (outpatient clinic based) cardiac rehabilitation program, who are offered the opportunity to perform the rehab remotely (e.g. at home, not at the clinic), using a remote monitor and smart-phone application.

Study Overview

Detailed Description

In spite of the fact that cardiac rehabilitation has been shown to be beneficial to patients who have had a cardiac event, such as a heart attack, only 5% of eligible patients complete this program. Some of the reasons cited include limited facility access, travel time and cost.

We are testing the hypothesis that cardiac rehab compliance will be greater if patients are offered the opportunity, and associated technology, to perform cardiac rehab anywhere.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63117
        • Saint Louis University - SLUCare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • referred to SLU cardiac rehab facility

Exclusion Criteria:

  • does not own app compatible smart phone
  • dementia
  • syncope
  • valvular disease
  • life expectancy < 1 year
  • non-English speaking
  • unstable angina
  • decompensated congestive heart failure
  • ventricular arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of patients completing remote rehab program compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
Immediately after cardiac rehab completion or stoppage

Secondary Outcome Measures

Outcome Measure
Time Frame
Six minute walk test compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
Immediately after cardiac rehab completion or stoppage
depression score vs case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
Immediately after cardiac rehab completion or stoppage
Average number of minutes in exercise rehab compared to case controls
Time Frame: Immediately after cardiac rehab completion or stoppage
Immediately after cardiac rehab completion or stoppage

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa Alderson, MD, St. Louis University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2018

Primary Completion (Actual)

September 30, 2019

Study Completion (Actual)

September 30, 2019

Study Registration Dates

First Submitted

April 2, 2018

First Submitted That Met QC Criteria

April 2, 2018

First Posted (Actual)

April 9, 2018

Study Record Updates

Last Update Posted (Actual)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 28544

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

no current plan

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Referred by Cardiologist for Phase 2 Cardiac Rehabilitation

Clinical Trials on Remote Cardiac Rehab

Subscribe